Company Filing History:
Years Active: 2021-2022
Title: Ariane Lozac'hmeur: Innovator in Cancer Detection Technologies
Introduction
Ariane Lozac'hmeur is a notable inventor based in Chicago, IL (US). She has made significant contributions to the field of cancer detection through her innovative patents. With a total of 2 patents, her work focuses on advanced methodologies for identifying cancer conditions and understanding the genetic factors involved.
Latest Patents
One of her latest patents is titled "Detection of human leukocyte antigen loss of heterozygosity." This patent outlines processes for detecting loss of heterozygosity of Human Leukocyte Antigen (HLA) in a subject using next-generation sequencing (NGS) data. The processes include aligning NGS data, identifying unmapped and mapped reads, updating reference data, and feeding sequence reads to an HLA typing process. This ultimately aids in identifying candidate HLA alleles and determining the loss of heterozygosity (LOH) status for each HLA allele. A comprehensive report can be generated detailing the LOH statuses for each HLA allele.
Another significant patent is focused on "Systems and methods for using sequencing data for pathogen detection." This invention provides systems and methods for training a classifier to differentiate between cancer conditions associated with oncogenic pathogenic infections and those that are not. It also includes systems for treating cancer based on its association with oncogenic pathogenic infections.
Career Highlights
Ariane has worked with prominent companies such as Tempus Labs, Inc. and Tempus AI, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in cancer detection technologies.
Collaborations
Ariane has collaborated with talented individuals in her field, including Denise Lau and Aly Azeem Khan. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Ariane Lozac'hmeur is a pioneering inventor whose work in cancer detection technologies is making a significant impact. Her innovative patents and collaborations highlight her dedication to advancing medical science and improving patient outcomes.